MAP1LC3A
Microtubule-associated protein 1 light chain 3 alpha
Also known as: ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3, MLP3A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H492
- Gene
- MAP1LC3A
- Ensembl
- ENSG00000101460
- Chromosome
- 20
- Canonical length
- 121 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Primary cilium,Centriolar satellite
OverviewNCBI Gene
MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. The expression of variant 1 is suppressed in many tumor cell lines, suggesting that may be involved in carcinogenesis. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
121 residues, UniProt reviewed canonical sequence.
>Q9H492|MAP1LC3A
1 MPSDRPFKQR RSFADRCKEV QQIRDQHPSK IPVIIERYKG EKQLPVLDKT KFLVPDHVNM
61 SELVKIIRRR LQLNPTQAFF LLVNQHSMVS VSTPIADIYE QEKDEDGFLY MVYASQETFG
121 FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP1LC3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 222 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 222 nTPM
- cerebral cortex: 218 nTPM
- midbrain: 197 nTPM
- hippocampal formation: 193 nTPM
- cerebellum: 190 nTPM
- amygdala: 190 nTPM
Single-cell type
- late spermatids: 1,114 nCPM
- syncytiotrophoblasts: 319 nCPM
- esophageal apical cells: 295 nCPM
- decidual stromal cells: 228 nCPM
- hepatic stellate cells: 168 nCPM
- early spermatids: 152 nCPM
Immune cell
- neutrophil: 86 nTPM
- T-reg: 12 nTPM
- eosinophil: 11 nTPM
- memory B-cell: 9.4 nTPM
- naive B-cell: 6.1 nTPM
- memory CD4 T-cell: 5.5 nTPM
Brain region
- pons: 266 nTPM
- hypothalamus: 247 nTPM
- medulla oblongata: 223 nTPM
- midbrain: 221 nTPM
- cerebral cortex: 203 nTPM
- hippocampal formation: 189 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 1.46
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome assembly
- autophagosome maturation
- autophagy of mitochondrion
- cellular response to amino acid starvation
- cellular response to copper ion
- cellular response to hydrogen peroxide
- cellular response to nitrogen starvation
- cellular response to oxygen-glucose deprivation
- cellular response to starvation
- JNK cascade
- macroautophagy
- mitophagy
- p38MAPK cascade
- response to iron(II) ion
- response to lead ion
- SMAD protein signal transduction
Molecular functions
- microtubule binding
- phosphatidylethanolamine binding
- phospholipid binding
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP1LC3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP1LC3A as an antibody target. Whether an autoantibody or antibody against MAP1LC3A could matter depends on whether native MAP1LC3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP1LC3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP1LC3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...